Novo Nordisk A/S (NVO)

Last Closing Price: 37.82 (2026-11-20)

Operating Income (Quarterly)

Operating Income: The income after operating expenses.

Novo Nordisk A/S (NVO) had Operating Income of $3.54B for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$12.20B
$2.58B
$2.81B
$9.39B
$8.65B
Operating Income
$3.54B
$-242.86M
$3.30B
$3.30B
$2.58B
$2.58B
$2.58B
$2.58B
$3.54B
$5.73B
4.41B
4.42B
$0.59
$0.58
Balance Sheet Financials
$32.46B
$37.08B
$59.81B
$92.27B
$38.42B
$18.13B
$20.31B
$58.73B
$33.54B
$16.33B
$33.54B
--
Cash Flow Statement Financials
$18.63B
$-6.09B
$-9.79B
$4.08B
$6.80B
$2.72B
--
$-7.99B
--
Fundamental Metrics & Ratios
0.84
--
--
0.35
0.62
76.97%
29.06%
29.06%
--
27.06%
21.14%
$12.90B
--
--
--
0.13
0.36
0.72
125.70
7.69%
15.79%
2.79%
4.99%
--
$2.92
$4.22